Table 3.
Pt | Year of Dx | Age | Sex | Tumor size (cm), site | Child-pugh class | Initial tumor ablation | Antiviral therapy | Recurrence (months) | Retreatment | Survival (months) | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 1991 | 66 | M | 2 Rt | C | TACE | None | 2 | TACE | 3 | Dead |
2 | 1994 | 58 | M | 3 Rt | A | Resection | None | 20 | Resectionx2 | 36 | Dead |
3 | 1996 | 46 | M | 4 Lt | A | Cryoablation | None | 5 | Cryo, TACE | 17 | Dead |
4 | 1996 | 53 | M | 3 Rt | A | Cryoablation | None | 5 | TACE, chemo | 9 | Dead |
5 | 1996 | 53 | M | 4 Rt | A | Resection | None | 12 | TACEx2 | 16 | Dead |
6 | 1997 | 59 | M | 1 Rt | B | PCEI | None | 2 | ChemoRx | 6 | Dead |
7 | 1999 | 48 | M | 2.5 Rt | C | TACE | None | 3 | TACE multiple | 16 | Dead |
8 | 1999 | 60 | M | 2.5 Lt | A | TACE, RFA | None | 9 | TACE | 17 | Dead |
9 | 1999 | 53 | M | 6.9 Rt | B | TACE | None | 6 | Incomplete Ablation, multiple times | 6 | Dead |
HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization; PCEI, percutaneous ethanol injection; RFA, radiofrequency ablation.